Friday, 23 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleSeeking Alpha· March 4, 2026

B&G Foods outlines $1.655B–$1.695B sales target for 2026 as portfolio transformation accelerates

View original at seekingalpha.com
B&G Foods outlines $1.655B–$1.695B sales target for 2026 as portfolio transformation accelerates Earnings Call Insights: B&G Foods (BGS) Q4 2025 MANAGEMENT VIEW * Kenneth Keller, President, CEO & Director, opened by announcing a major portfolio reshaping milestone, stating the divestiture of the Green Giant U.S…
Opening lines of the source · Seeking Alpha · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Based on 2026 guidance, adjusted diluted earnings per share expected to be in range of $0.55 to $0.65

    80% confidence
  • The divestiture of Green Giant U.S. frozen business is the largest piece in portfolio transformation that should result in stronger focus, simplification, greater synergies and higher margins across core shelf-stable business lines

    80% confidence
  • Base business trends on remaining core Meals, Spices & Flavor Solutions and Specialty businesses expected to improve plus 0.4% versus last year

    80% confidence
  • Net result of divestitures and acquisition will deliver more focused portfolio expected to generate positive adjusted EBITDA growth, stronger cash flows, lower working capital intensity, reduced leverage and higher gross and adjusted EBITDA margins

    80% confidence
  • Company is moving towards leverage targets but not there yet

    80% confidence
  • 4% quarter-to-date base business growth attributed to both weather-driven baking staples demand and lapping last year's trade inventory reduction

    80% confidence
  • Q4 2025 generated $539.6 million in net sales, net loss of $15.2 million or $0.19 per diluted share, adjusted net income of $22.8 million or $0.28 per adjusted diluted share, $84.7 million in adjusted EBITDA and adjusted EBITDA as percentage of net sales of 15.7%

    80% confidence
  • Spices and seasonings has been pretty resilient and posting good numbers, part of gradual improvement in U.S. food retail consumption

    80% confidence
  • Q4 base business net sales improved to down approximately 2.4% compared to down 2.7% in Q3

    80% confidence
  • Seneca co-pack agreement has cost-plus structure ensuring profitability

    80% confidence
  • Company is on way to 4.5x to 5.5x long-term leverage target but still has more work to do

    80% confidence
  • Company will spend very similar amount in 2026 on brand support as in 2025, with different portfolio allocation and probable increase in spending on a few brands

    80% confidence
  • Green Giant U.S. frozen business was not the right fit due to seasonal production, geographic complexity, and high working capital intensity

    80% confidence
  • Proceeds from divestitures would be used to fund new acquisitions

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,475 source documents archived
Query this data → isubstrate.com